A comparison of automated atrophy measures across the frontotemporal dementia spectrum: Implications for trials.

These analyses demonstrated there were highly significant differences ( p less than 0.001) between all clinical, genetic and pathology patient subgroups and controls for almost all longitudinal measures, with the exception of the indirect measure using MALP-EM_BV, SIENAX_BV and Freesurfer_BV ( Supplementary Table S6 provides the full regression results). 3.3.

also in 132,142 other papers